ArticleJournal of the National Cancer Institute2026
Influence of treatment, genetic predisposition, and lifestyle on cardiovascular risk factors among cancer survivors.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAs traditional cardiovascular risk factors increase cardiovascular risk with a near-multiplicative effect among childhood cancer survivors, our purpose was to evaluate the combined contributions of population-based polygenic risk scores and lifestyle behaviors to cardiovascular risk factors to identify targets for surveillance and risk prevention.
methodsParticipants included 2610 European ancestry childhood cancer survivors (mean [SD] age = 34.6 [9.5] years). Using phenotype-specific, population-based polygenic risk scores for low-density lipoprotein and high-density lipoprotein cholesterol, triglycerides, fasting glucose, hemoglobin A1c, systolic blood pressure (BP) and diastolic BP, childhood cancer survivors were classified with low (lowest quintile), intermediate (middle 3 quintiles), or high genetic risk (highest quintile). Lifestyle (good, intermediate, poor) was based on 4 factors (smoking, physical activity, diet quality, obesity). Multiple linear regression was used to assess associations between lifestyle and genetic risk with each cardiovascular risk factor, adjusting for cancer therapies and medications.
resultsWorsening cardiovascular risk factor profiles were associated with poorer lifestyle (ie, decreasing number of positive health habits) and increasing genetic risk. For example, poor lifestyle and high genetic risk were associated with a mean (SE) of 5.4 (1.0) and 5.0 (1.1) mmHg increase in systolic BP compared with good lifestyle and low genetic risk, respectively, and 3.4 (0.7) and 4.4 (0.7) mmHg increase in diastolic BP. Among childhood cancer survivors with high genetic risk, mean (SE) diastolic BP (mean = -4.6 [2.2] mmHg, P = .034) and fasting glucose (mean = -5.0 [2.1] mg/dL, P < .001) were lower among childhood cancer survivors with good vs poor lifestyle, while mean high-density lipoprotein was higher (mean = 12.9 [1.9] mg/dL, P < .001).
conclusionAmong childhood cancer survivors, lifestyle is associated with increased risk of cardiovascular risk factors independent of genetic risk and treatment, highlighting the importance of developing interventions targeting lifestyle in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.